Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
29.95%
↑ 106% above average
Average (14q)
-487.67%
Historical baseline
Range
High:80.66%
Low:-7077.78%
Volatility
-1467.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 29.95% |
| Q2 2025 | 10.53% |
| Q1 2025 | 24.00% |
| Q4 2024 | -26.15% |
| Q3 2024 | 2.68% |
| Q2 2024 | -44.52% |
| Q1 2024 | -17.42% |
| Q4 2023 | -10.92% |
| Q3 2023 | 7.03% |
| Q2 2023 | 80.66% |
| Q1 2023 | -2.48% |
| Q4 2022 | -7077.78% |
| Q3 2022 | -108.33% |
| Q2 2022 | -182.35% |
| Q1 2022 | 0.00% |